SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-20-139263
Filing Date
2020-05-11
Accepted
2020-05-11 17:16:03
Documents
2
Group Members
AARON I. DAVISBOXER ASSET MANAGEMENT INC.JOE LEWISMVA INVESTORS, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G d923589dsc13g.htm SC 13G 100349
2 EX-99.1 d923589dex991.htm EX-99.1 6459
  Complete submission text file 0001193125-20-139263.txt   108450
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Subject) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89449 | Film No.: 20866031
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11682 EL CAMINO REAL SUITE 320 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 320 SAN DIEGO CA 92130 (858) 400-3112
Boxer Capital, LLC (Filed by) CIK: 0001465837 (see all company filings)

IRS No.: 203828456 | State of Incorp.: DE
Type: SC 13G